Catania, August 25, 2020 - SIFI, an Italian leader in ophthalmology, is pleased to announce the successful conclusion of a Phase 3 clinical trial aimed at demonstrating the non-inferiority of NETILDEX® gel administered twice daily (BID) vs. NETIL...

> leggi

Catania, July 24th 2020 – The University of Messina and SIFI, leading Italian pharmaceutical company in Ophthalmology, founded and strongly rooted in Sicily, announce they have signed a multi-year cooperation agreement to develop joint programm...

> leggi

Catania, Italy - March 23, 2020 - SIFI, the main Italian ophthalmic pharmaceutical company, is actively involved in the fight against COVID-19, and is alongside physicians, nurses and health personnel, to help face together the ongoing emergency. The...

> leggi

MONTREAL, CANADA - 23 ottobre 2019 - Knight Therapeutics Inc. (TSX: GUD) ("Knight"), una delle principali società farmaceutiche canadesi, e SIFI SpA ("SIFI"), un'importante società farmaceutica oftalmica italiana focalizzata...

> leggi

Da oggi Fabrizio Folco assume la guida dell’organizzazione aziendale nel mercato italiano Catania, 20 settembre 2019 - SIFI, la principale società farmaceutica oftalmica italiana, leader nello sviluppo di soluzioni innovative per il tratta...

> leggi